Search

everythinglearnresearchcommunity

for

Search:↓

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Topical tacalcitol ointment can help improve symptoms of EFFC.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A new lipid-based formula using myristyl myristate can improve estradiol treatment for hair loss.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

BAF200 is essential for proper heart and coronary artery formation.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Concurrent laser and isotretinoin treatment improves acne scars more than delayed treatment.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

A new compound shows promise as a topical treatment for hair loss.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.